Acura Pharm

Palatine, United States Founded: 1935 • Age: 91 yrs Listed
Abuse-deterrent drug delivery technologies are developed for medication safety.

About Acura Pharm

Acura Pharm is a publicly listed company based in Palatine (United States) founded in 1935. Abuse-deterrent drug delivery technologies are developed for medication safety. Acura Pharm offers products and services including LIMITX Technology and AVERSION Technology. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas. Its legal entity is Acura Pharmaceuticals, Inc.

Company details

Acura Pharm was founded in 1935 and is based in Palatine, United States. Operations in the pharmaceutical sector involve research, development, and commercialization of abuse-deterrent drug delivery technologies. Proprietary platforms are licensed to other companies for product applications. These technologies are engineered to reduce overdose risks, prevent tampering methods like snorting or injection, and limit pseudoephedrine extraction for illicit uses such as methamphetamine production.

  • Headquarters Palatine, United States
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website acurapharm.com
  • Social LinkedIn
  • Legal Name Acura Pharmaceuticals, Inc.
Key Metrics
  • Annual Revenue
    $1.56 M (USD)
    -56.22
    as on Dec 31, 2021
  • Net Profit
    -$879 K (USD)
    27.24
    as on Dec 31, 2021
  • EBITDA
    -$1.08 M (USD)
    -3177.14
    as on Dec 31, 2021
  • Latest Funding Round
    $1.8M (USD), Debt – Conventional

    Oct 2018

  • Investors
    HHS

    & 1 more

Products & Services of Acura Pharm

Acura Pharm offers a comprehensive portfolio of products and services, including LIMITX Technology and AVERSION Technology.

LIMITX Technology
Drug Delivery Technology

LIMITX Technology is used to minimize overdose risks by retarding the release of active ingredients when excessive tablets are ingested.

AVERSION Technology
Abuse Deterrent Technology

AVERSION Technology is applied to incorporate barriers that discourage tampering and abuse through methods like injection or snorting.

Funding Insights of Acura Pharm

  • Total Rounds 4
  • Last Round Debt – Conventional β€” $1.8M
  • First Round $300,000

    (Aug 2014)

  • Investors Count 2

All 4 funding rounds of Acura Pharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2018$1.8MDebt – Conventional––
Jul 2017$4MPost-IPO––
–
Sep 2014$299,694Grant––
Aug 2014$300,000Grant––
–
Valuation history

2 investors in total: 1 institutional and 1 angel.

Investors in Acura Pharm

Acura Pharm has secured backing from 2 investors, including angel and institutional investors. Prominent investors backing the company include HHS and John Schutte.

All
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov

John Schutte

unknown_aa49cba2ea6a49a6b
Premium access

Investor details for Acura Pharm

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

IPO & Listings of Acura Pharm

Acura Pharm is a publicly listed company on the OTC with ticker symbol ACUR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date17 Mar 1992
  • Listed onOTCMKTS: ACUR
  • Listed entityAcura Pharmaceuticals, Inc.
  • Exchange sectorHealth technology
  • ISINUS00509L8028
  • Share price$0.00 · 2026-10-06
  • Market capitalisation$6,666.18
  • Volume (last session)34,348

Financials of Acura Pharm

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2021$1.6M-$879,000-$1.1M
2020$3.6M-$1.2M$35,000
Premium access

Detailed financial statements for Acura Pharm

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Acura Pharm

4 dated milestones of Acura Pharm across 83 years, from founding to its latest funding, stage changes and deals.

  1. Founded Acura Pharm is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $300K.
  4. Funding Latest funding round, Debt – Conventional, of $1.8M.

Web traffic of Acura Pharm

The website of Acura Pharm (acurapharm.com) receives about 2.4K visits a month and ranks #8,922,263 among all websites worldwide, #7,537 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    2.4K

    ▲ 43% vs previous month

  • Global rank
    #8,922,263

    among all websites

  • Category rank
    #7,537

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Acura Pharm. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
risingpharma.com
100%
5.1K#2,708,467View details
amneal.com
98%
26.8K#959,075View details
west-ward.com
west-ward.com
98%
–
clementiapharma.com
96%
View details
purduepharma.com
95%
26.1K#875,078View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 12 similar websites and full traffic analytics for Acura Pharm

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 12 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Acura Pharm (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Acura Pharm

Premium access

Complete news archive for Acura Pharm

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Acura Pharm

Acura Pharm was founded in 1935 and raised its 1st funding round 79 years after it was founded.

Acura Pharm is headquartered in Palatine, United States. It is registered at Palatine, Illinois, United States.

Annual revenue of Acura Pharm is $1.56M as on Dec 31, 2021.

Acura Pharm was founded in 1935 and is based in Palatine, United States. Operations in the pharmaceutical sector involve research, development, and commercialization of abuse-deterrent drug delivery technologies. Proprietary platforms are licensed to other companies for product applications. These technologies are engineered to reduce overdose risks, prevent tampering methods like snorting or injection, and limit pseudoephedrine extraction for illicit uses such as methamphetamine production.

Acura Pharm offers LIMITX Technology and AVERSION Technology.

Yes, Acura Pharm is publicly traded on OTC under the ticker symbol ACUR.

Acura Pharm has 2 investors. Key investors include HHS, and John Schutte.

Acura Pharm operates through Acura Pharmaceuticals, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available